Arcturus Therapeutics Holdings Stock Price History
| ARCT Stock | USD 25.98 0.34 1.29% |
Below is the normalized historical share price chart for Arcturus Therapeutics Holdings extending back to May 22, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arcturus Therapeutics stands at 25.98, as last reported on the 22nd of April, with the highest price reaching 26.88 and the lowest price hitting 25.57 during the day.
If you're considering investing in Arcturus Stock, it is important to understand the factors that can impact its price. Arcturus Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0931, which signifies that the company had a -0.0931% return per unit of standard deviation over the last 3 months. Arcturus Therapeutics Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Arcturus Therapeutics' risk adjusted performance of (0.03), and Mean Deviation of 3.17 to double-check the risk estimate we provide.
At this time, Arcturus Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 28 M in 2024, whereas Sale Purchase Of Stock is likely to drop slightly above 1.5 M in 2024. . At this time, Arcturus Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 3.17 in 2024, whereas Price Earnings To Growth Ratio is likely to drop 0.06 in 2024. Arcturus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of April 2020 | 200 Day MA 29.9996 | 50 Day MA 35.0534 | Beta 2.601 |
Arcturus |
Sharpe Ratio = -0.0931
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARCT |
Estimated Market Risk
| 4.03 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Arcturus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcturus Therapeutics by adding Arcturus Therapeutics to a well-diversified portfolio.
Price Book 2.9456 | Enterprise Value Ebitda (23.11) | Price Sales 4.9103 | Shares Float 24.6 M | Wall Street Target Price 67.63 |
Arcturus Therapeutics Stock Price History Chart
There are several ways to analyze Arcturus Stock price data. The simplest method is using a basic Arcturus candlestick price chart, which shows Arcturus Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 27, 2024 | 42.99 |
| Lowest Price | April 19, 2024 | 25.98 |
Arcturus Therapeutics April 22, 2024 Stock Price Synopsis
Various analyses of Arcturus Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Arcturus Stock. It can be used to describe the percentage change in the price of Arcturus Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Arcturus Stock.| Arcturus Therapeutics Price Daily Balance Of Power | (0.26) | |
| Arcturus Therapeutics Price Action Indicator | (0.41) | |
| Arcturus Therapeutics Price Rate Of Daily Change | 0.99 |
Arcturus Therapeutics April 22, 2024 Stock Price Analysis
Arcturus Stock Price History Data
The price series of Arcturus Therapeutics for the period between Tue, Jan 23, 2024 and Mon, Apr 22, 2024 has a statistical range of 17.01 with a coefficient of variation of 10.22. The prices are distributed with arithmetic mean of 34.77. The median price for the last 90 days is 34.63. The company had 1:7 stock split on 16th of November 2017. Arcturus Therapeutics issued dividends on 2017-11-16.| Open | High | Low | Close | Volume | ||
04/22/2024 | 26.06 | 26.88 | 25.57 | 25.98 | ||
| 04/19/2024 | 26.06 | 26.88 | 25.57 | 25.98 | 626,328 | |
| 04/18/2024 | 27.14 | 27.45 | 26.26 | 26.32 | 607,514 | |
| 04/17/2024 | 30.25 | 30.89 | 27.47 | 27.64 | 621,074 | |
| 04/16/2024 | 29.06 | 30.76 | 28.79 | 30.13 | 385,057 | |
| 04/15/2024 | 30.57 | 30.68 | 29.08 | 29.31 | 609,596 | |
| 04/12/2024 | 32.28 | 32.30 | 30.02 | 30.43 | 405,050 | |
| 04/11/2024 | 32.32 | 33.11 | 31.86 | 32.54 | 547,647 | |
| 04/10/2024 | 30.46 | 31.94 | 30.14 | 31.84 | 689,564 | |
| 04/09/2024 | 30.83 | 31.71 | 30.30 | 31.66 | 822,008 | |
| 04/08/2024 | 32.01 | 32.01 | 30.48 | 30.93 | 392,561 | |
| 04/05/2024 | 30.33 | 32.30 | 29.69 | 31.97 | 309,514 | |
| 04/04/2024 | 32.87 | 33.43 | 30.23 | 30.60 | 509,893 | |
| 04/03/2024 | 32.09 | 33.33 | 32.09 | 32.74 | 546,231 | |
| 04/02/2024 | 32.45 | 33.27 | 31.54 | 32.22 | 379,855 | |
| 04/01/2024 | 33.77 | 33.99 | 32.21 | 33.08 | 425,303 | |
| 03/28/2024 | 33.04 | 33.84 | 32.00 | 33.77 | 527,839 | |
| 03/27/2024 | 32.37 | 33.00 | 31.76 | 32.86 | 867,781 | |
| 03/26/2024 | 35.12 | 35.48 | 31.76 | 32.13 | 554,648 | |
| 03/25/2024 | 33.73 | 35.67 | 33.71 | 34.79 | 800,820 | |
| 03/22/2024 | 33.04 | 34.33 | 32.60 | 33.90 | 327,395 | |
| 03/21/2024 | 33.42 | 34.13 | 32.92 | 33.13 | 328,175 | |
| 03/20/2024 | 33.33 | 33.76 | 32.52 | 33.15 | 620,769 | |
| 03/19/2024 | 32.67 | 35.02 | 32.52 | 33.76 | 700,476 | |
| 03/18/2024 | 36.08 | 36.96 | 33.02 | 33.13 | 586,836 | |
| 03/15/2024 | 36.04 | 37.31 | 36.04 | 36.31 | 722,545 | |
| 03/14/2024 | 37.50 | 37.82 | 36.00 | 36.37 | 490,865 | |
| 03/13/2024 | 38.75 | 39.58 | 37.63 | 37.90 | 629,770 | |
| 03/12/2024 | 38.01 | 39.55 | 37.66 | 38.69 | 740,879 | |
| 03/11/2024 | 37.82 | 38.98 | 37.01 | 37.89 | 480,775 | |
| 03/08/2024 | 35.99 | 39.70 | 35.06 | 36.86 | 456,791 | |
| 03/07/2024 | 38.17 | 38.72 | 37.03 | 37.19 | 523,274 | |
| 03/06/2024 | 38.03 | 38.64 | 37.02 | 37.78 | 840,774 | |
| 03/05/2024 | 37.37 | 38.19 | 37.10 | 37.56 | 316,907 | |
| 03/04/2024 | 40.40 | 40.40 | 37.47 | 37.65 | 344,262 | |
| 03/01/2024 | 38.82 | 40.48 | 38.77 | 39.73 | 589,432 | |
| 02/29/2024 | 41.24 | 41.50 | 38.40 | 38.76 | 499,797 | |
| 02/28/2024 | 42.36 | 42.92 | 40.18 | 40.18 | 408,940 | |
| 02/27/2024 | 41.64 | 43.81 | 41.54 | 42.99 | 514,999 | |
| 02/26/2024 | 37.41 | 41.14 | 37.41 | 40.94 | 620,447 | |
| 02/23/2024 | 37.60 | 38.03 | 37.01 | 37.42 | 339,807 | |
| 02/22/2024 | 35.52 | 37.81 | 34.76 | 37.44 | 417,310 | |
| 02/21/2024 | 34.86 | 35.70 | 34.50 | 35.28 | 364,134 | |
| 02/20/2024 | 36.28 | 36.98 | 35.69 | 36.21 | 396,724 | |
| 02/16/2024 | 37.50 | 37.99 | 36.61 | 36.92 | 340,304 | |
| 02/15/2024 | 38.92 | 39.10 | 37.69 | 38.19 | 382,643 | |
| 02/14/2024 | 39.60 | 39.83 | 38.16 | 38.46 | 587,982 | |
| 02/13/2024 | 39.42 | 40.21 | 37.20 | 38.77 | 566,385 | |
| 02/12/2024 | 39.98 | 41.68 | 39.55 | 41.62 | 424,156 | |
| 02/09/2024 | 38.23 | 39.88 | 37.40 | 39.64 | 467,118 | |
| 02/08/2024 | 37.93 | 39.00 | 37.58 | 37.91 | 453,820 | |
| 02/07/2024 | 37.73 | 38.27 | 37.04 | 37.30 | 248,234 | |
| 02/06/2024 | 35.14 | 37.85 | 34.72 | 37.75 | 418,457 | |
| 02/05/2024 | 34.62 | 35.35 | 33.43 | 35.07 | 281,882 | |
| 02/02/2024 | 34.06 | 35.52 | 33.42 | 34.72 | 331,937 | |
| 02/01/2024 | 33.31 | 35.00 | 32.33 | 34.67 | 450,585 | |
| 01/31/2024 | 32.46 | 34.31 | 32.00 | 32.97 | 380,669 | |
| 01/30/2024 | 33.34 | 33.34 | 31.99 | 32.70 | 251,188 | |
| 01/29/2024 | 31.93 | 33.66 | 31.05 | 33.63 | 352,317 | |
| 01/26/2024 | 32.90 | 33.42 | 31.53 | 31.72 | 258,699 | |
| 01/25/2024 | 32.69 | 33.73 | 32.67 | 32.89 | 271,434 |
About Arcturus Therapeutics Stock history
Arcturus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcturus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcturus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcturus Therapeutics stock prices may prove useful in developing a viable investing in Arcturus Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.6 M | 28 M | |
| Net Income Applicable To Common Shares | 8.4 M | 8.8 M |
Arcturus Therapeutics Quarterly Net Working Capital |
|
Arcturus Therapeutics Stock Technical Analysis
Arcturus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Arcturus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arcturus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Arcturus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcturus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.11) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcturus Therapeutics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Arcturus Therapeutics information on this page should be used as a complementary analysis to other Arcturus Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Arcturus Stock analysis
When running Arcturus Therapeutics' price analysis, check to measure Arcturus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcturus Therapeutics is operating at the current time. Most of Arcturus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arcturus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcturus Therapeutics' price. Additionally, you may evaluate how the addition of Arcturus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Arcturus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcturus Therapeutics. If investors know Arcturus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcturus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 6.264 | Quarterly Revenue Growth (0.81) | Return On Assets (0.11) | Return On Equity (0.11) |
The market value of Arcturus Therapeutics is measured differently than its book value, which is the value of Arcturus that is recorded on the company's balance sheet. Investors also form their own opinion of Arcturus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Arcturus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcturus Therapeutics' market value can be influenced by many factors that don't directly affect Arcturus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcturus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcturus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcturus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.